A phase 2 study of nilotinib in pediatric patients with CML: Long-term update on growth retardation and safety

Nobuko Hijiya*, Alexey Maschan, Carmelo Rizzari, Hiroyuki Shimada, Carlo Dufour, Hiroaki Goto, Hyoung Jin Kang, Terri Guinipero, Zeynep Karakas, Francisco Bautista, Stephane Ducassou, Keon Hee Yoo, Christian Michel Zwaan, Frederic Millot, Briana Patterson, Jill Samis, Paola Aimone, Alex Allepuz, Ksenia Titorenko, Darintr Sosothikul

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 study of nilotinib in pediatric patients with CML: Long-term update on growth retardation and safety'. Together they form a unique fingerprint.

Medicine & Life Sciences